Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib with or without TACE in advanced HCC
NCT01906216Phase 3Completed
- Sponsor
- Air Force Medical University
- Start
- Sep 2013
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Air Force Medical University. Started Sep 2013; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01906216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01906216.